
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery
Yutian Zou, Jindong Xie, Shaoquan Zheng, et al.
International Journal of Surgery (2022) Vol. 107, pp. 106936-106936
Open Access | Times Cited: 259
Yutian Zou, Jindong Xie, Shaoquan Zheng, et al.
International Journal of Surgery (2022) Vol. 107, pp. 106936-106936
Open Access | Times Cited: 259
Showing 1-25 of 259 citing articles:
The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer
Yutian Zou, Feng Ye, Yanan Kong, et al.
Advanced Science (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 169
Yutian Zou, Feng Ye, Yanan Kong, et al.
Advanced Science (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 169
Integrated machine learning survival framework develops a prognostic model based on inter-crosstalk definition of mitochondrial function and cell death patterns in a large multicenter cohort for lower-grade glioma
Qin Hu, Aimitaji Abulaiti, Aierpati Maimaiti, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Qin Hu, Aimitaji Abulaiti, Aierpati Maimaiti, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 51
Exploring the role of sphingolipid-related genes in clinical outcomes of breast cancer
Shengbin Pei, Pengpeng Zhang, Lili Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 47
Shengbin Pei, Pengpeng Zhang, Lili Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 47
HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer
Yiran Liang, Yajie Wang, Yan Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 46
Yiran Liang, Yajie Wang, Yan Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 46
Lactate in the tumor microenvironment: A rising star for targeted tumor therapy
Zhangzuo Li, Qi Wang, Xu‐Feng Huang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 44
Zhangzuo Li, Qi Wang, Xu‐Feng Huang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 44
Machine learning reveals diverse cell death patterns in lung adenocarcinoma prognosis and therapy
Shun Wang, Ruohuang Wang, Dingtao Hu, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 35
Shun Wang, Ruohuang Wang, Dingtao Hu, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 35
Multi‐omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple‐negative breast cancer
Jindong Xie, Xinpei Deng, Yi Xie, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 32
Jindong Xie, Xinpei Deng, Yi Xie, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 32
Leveraging mitochondrial-programmed cell death dynamics to enhance prognostic accuracy and immunotherapy efficacy in lung adenocarcinoma
Lianmin Zhang, Yanan Cui, Guangyao Zhou, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e010008-e010008
Open Access | Times Cited: 25
Lianmin Zhang, Yanan Cui, Guangyao Zhou, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 10, pp. e010008-e010008
Open Access | Times Cited: 25
Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 11
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 11
The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance
Jindong Xie, Junsheng Zhang, W. H. Tian, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15647-15647
Open Access | Times Cited: 39
Jindong Xie, Junsheng Zhang, W. H. Tian, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15647-15647
Open Access | Times Cited: 39
Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway
Aiqun Liu, Baohong Jiang, Cailu Song, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 39
Aiqun Liu, Baohong Jiang, Cailu Song, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 39
Different types of cell death in diabetic endothelial dysfunction
Jieru Shen, Wenqing San, Yangyang Zheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115802-115802
Open Access | Times Cited: 37
Jieru Shen, Wenqing San, Yangyang Zheng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115802-115802
Open Access | Times Cited: 37
PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma
Fei Song, Chenggui Wang, Jiazhen Mao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Fei Song, Chenggui Wang, Jiazhen Mao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer
Pengfei Huang, Xinyue Zhou, Minying Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Pengfei Huang, Xinyue Zhou, Minying Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation
Qi Wang, Zhangzuo Li, Shujing Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Qi Wang, Zhangzuo Li, Shujing Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 24
Pan-cancer evaluation of regulated cell death to predict overall survival and immune checkpoint inhibitor response
Wei Zhang, Yongwei Zhu, Hongyi Liu, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 13
Wei Zhang, Yongwei Zhu, Hongyi Liu, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 13
Single‐cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target
Jindong Xie, Anli Yang, Qianwen Liu, et al.
Cell Proliferation (2024) Vol. 57, Iss. 11
Open Access | Times Cited: 12
Jindong Xie, Anli Yang, Qianwen Liu, et al.
Cell Proliferation (2024) Vol. 57, Iss. 11
Open Access | Times Cited: 12
Machine learning-based investigation of regulated cell death for predicting prognosis and immunotherapy response in glioma patients
Wei Zhang, Ruiyue Dang, Hongyi Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Wei Zhang, Ruiyue Dang, Hongyi Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer
Ze Yuan, Binbin Li, Wenmin Liao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Ze Yuan, Binbin Li, Wenmin Liao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8
RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancer
Yongzhou Luo, W. H. Tian, Da Kang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
Yongzhou Luo, W. H. Tian, Da Kang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 8
Multi‑omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machine learning study
Lele Ye, Chunhao Long, Binbing Xu, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Lele Ye, Chunhao Long, Binbing Xu, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
TOP2A inhibition and its cellular effects related to cell cycle checkpoint adaptation pathway
M. López, María Ángeles Fernández-Mimbrera, E. Gollini, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
M. López, María Ángeles Fernández-Mimbrera, E. Gollini, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Harnessing ferroptosis for precision oncology: challenges and prospects
Roberto Fernández-Acosta, Iuliana Vintea, Ine Koeken, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Roberto Fernández-Acosta, Iuliana Vintea, Ine Koeken, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
The significant clinical correlation of the intratumor oral microbiome in oral squamous cell carcinoma based on tissue-derived sequencing
Zhengrui Li, Rao Fu, Xutao Wen, et al.
Frontiers in Physiology (2023) Vol. 13
Open Access | Times Cited: 20
Zhengrui Li, Rao Fu, Xutao Wen, et al.
Frontiers in Physiology (2023) Vol. 13
Open Access | Times Cited: 20